CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 4 Grant or award Director acquired 630 shares (grant or award)
- 4 Grant or award Director acquired 630 shares (grant or award)
- 4 Grant or award Director acquired 630 shares (grant or award)
- 4 Grant or award Director acquired 630 shares (grant or award)
- 4 Grant or award Director acquired 630 shares (grant or award)
- 4 Grant or award Director acquired 630 shares (grant or award)
- 4 Grant or award Director acquired 630 shares (grant or award)
- 4 Grant or award Director acquired 630 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Option exercise President and COO acquired 1,755 shares (option exercise)
- DEFA14A Proxy Proxy Materials
- 4 Shares withheld for taxes Director gave up 391 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- 4 Shares withheld for taxes SVP, Gen. Counsel & Secretary gave up 1,015 shares (to pay taxes)
Page 25 of 115 · 2,300 filings